loadpatents
name:-0.024372100830078
name:-0.022692203521729
name:-0.0062060356140137
Crooks; Peter Anthony Patent Filings

Crooks; Peter Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Crooks; Peter Anthony.The latest application filed is for "vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse".

Company Profile
5.20.19
  • Crooks; Peter Anthony - Little Rock AR
  • Crooks; Peter Anthony - Nicholasville KY US
  • Crooks; Peter Anthony - Lexington KY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
Grant 11,406,642 - Geisler , et al. August 9, 2
2022-08-09
Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
App 20200290948 - DWOSKIN; Linda P. ;   et al.
2020-09-17
Vesicular Monoamine Transporter-2 Ligands And Their Use In The Treatment Of Psychostimulant Abuse
App 20200237688 - DWOSKIN; Linda P. ;   et al.
2020-07-30
Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
Grant 10,668,030 - Dwoskin , et al.
2020-06-02
DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion
App 20200093831 - Geisler; John Gerard ;   et al.
2020-03-26
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
Grant 10,548,900 - Geisler , et al. Fe
2020-02-04
Method of treating neuropathic pain
Grant 10,071,982 - Holtman , et al. September 11, 2
2018-09-11
Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
App 20170304227 - DWOSKIN; Linda ;   et al.
2017-10-26
DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases
App 20170252347 - Geisler; John Gerard ;   et al.
2017-09-07
Method Of Treating Neuropathic Pain
App 20160340335 - HOLTMAN; Joseph R. ;   et al.
2016-11-24
Use of tris-quaternary ammonium salts as pain modulating agents
Grant 9,155,733 - Holtman , et al. October 13, 2
2015-10-13
Method Of Treating Neuropathic Pain
App 20140011836 - HOLTMAN; Joseph R. ;   et al.
2014-01-09
Compounds capable of activating cholinergic receptors
Grant 7,790,757 - Caldwell , et al. September 7, 2
2010-09-07
Compounds Capable Of Activating Cholinergic Receptors
App 20100222395 - Caldwell; William Scott ;   et al.
2010-09-02
Compounds Capable Of Activating Cholinergic Receptors
App 20100204481 - Caldwell; William Scott ;   et al.
2010-08-12
Bioactive peptide-based probes
Grant 7,759,468 - Hicks , et al. July 20, 2
2010-07-20
Compounds Capable Of Activating Cholinergic Receptors
App 20100160390 - Caldwell; William Scott ;   et al.
2010-06-24
Compounds Capable of Activating Cholinergic Receptors
App 20080214628 - Caldwell; William Scott ;   et al.
2008-09-04
Compounds Capable of Activating Cholinergic Receptors
App 20080139809 - Caldwell; William Scott ;   et al.
2008-06-12
Compounds Capable of Activating Cholinergic Receptors
Grant 7,307,092 - Caldwell , et al. December 11, 2
2007-12-11
Compounds Capable of Activating Cholinergic Receptors
App 20060264445 - Caldwell; William Scott ;   et al.
2006-11-23
Compounds capable of activating cholinergic receptors
Grant 7,060,826 - Caldwell , et al. June 13, 2
2006-06-13
Compounds capable of activating cholinergic receptors
App 20050282846 - Caldwell, Willian Scott ;   et al.
2005-12-22
Compounds capable of activating cholinergic receptors
Grant 6,958,399 - Caldwell , et al. October 25, 2
2005-10-25
Compounds capable of activating cholinergic receptors
App 20050131034 - Caldwell, William Scott ;   et al.
2005-06-16
Compounds capable of activating cholinergic receptors
App 20040214835 - Caldwell, William Scott ;   et al.
2004-10-28
Pharmaceutical compositions for treating and/or preventing CNS disorders
Grant 6,624,173 - Crooks , et al. September 23, 2
2003-09-23
Pharmaceutical compositions and methods for use
App 20030045523 - Schmitt, Jeffrey Daniel ;   et al.
2003-03-06
Pharmaceutical compositions and methods for effecting dopamine release
Grant 6,525,065 - Caldwell , et al. February 25, 2
2003-02-25
Thermal vaporizing device for drug delivery
App 20020117175 - Kottayil, S. George ;   et al.
2002-08-29
Pharmaceutical compositions and methods for use
Grant 6,432,975 - Schmitt , et al. August 13, 2
2002-08-13
Pharmaceutical compositions and methods for use
Grant 6,417,359 - Crooks , et al. July 9, 2
2002-07-09
Compounds capable of activating cholinergic receptors
App 20020052497 - Caldwell, William Scott ;   et al.
2002-05-02
Pharmaceutical compositions and methods for use
Grant 6,211,372 - Crooks , et al. April 3, 2
2001-04-03
Certain 1-aza-tricyclo [3.3.1-1.sup.3,7 ] decane compounds
Grant 6,057,446 - Crooks , et al. May 2, 2
2000-05-02
Means to achieve sustained release of synergistic drugs by conjugation
Grant 6,051,576 - Ashton , et al. April 18, 2
2000-04-18
Pharmaceutical compositions and methods for use
Grant 5,986,100 - Crooks , et al. November 16, 1
1999-11-16
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
Grant 5,726,316 - Crooks , et al. March 10, 1
1998-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed